Stabilized liposomal nanohybrid cerasomes for drug delivery applications.

Paclitaxel loaded cerasomes exhibited sophisticated controlled release behavior and remarkably high stability towards surfactant solubilization, long-term storage, acidic treatment, and all factors susceptible to destabilize conventional liposomes, demonstrating that liposomal nanohybrid cerasomes can be a new promising drug delivery system.

[1]  K. Ariga,et al.  Preparation and Surface Modification of Novel Vesicular Nano-Particle “Cerasome” with Liposomal Bilayer and Silicate Surface , 2003 .

[2]  D. Lasič.  Recent developments in medical applications of liposomes: sterically stabilized liposomes in cancer therapy and gene delivery in vivo , 1997 .

[3]  K. Ariga,et al.  Size-Selective Organization of Silica and Silica-Like Particles on Solid Interfaces through Layer-by-Layer Assembly , 2004 .

[4]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.

[5]  T. Allen.  Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.

[6]  R. Gatenby,et al.  Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging. , 1989, Radiology.

[7]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[8]  F. Dosio,et al.  Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[9]  N. Tamai,et al.  Efficient fluorescence resonance energy transfer in highly stable liposomal nanohybrid cerasome. , 2009, Chemical communications.

[10]  Katsuhiko Ariga,et al.  Layered paving of vesicular nanoparticles formed with cerasome as a bioinspired organic-inorganic hybrid. , 2002, Journal of the American Chemical Society.

[11]  Chee Wee Gan,et al.  Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. , 2009, Biomaterials.

[12]  Katsuhiko Ariga,et al.  Preparation and characterization of a novel organic-inorganic nanohybrid "cerasome" formed with a liposomal membrane and silicate surface. , 2007, Chemistry.

[13]  T. Kuzel,et al.  Hand‐foot syndrome associated with liposome‐encapsulated doxorubicin therapy , 1995, Cancer.

[14]  Dae-Duk Kim,et al.  Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. , 2007, International journal of pharmaceutics.

[15]  Y. Sasaki,et al.  Cerasome as an infusible, cell-friendly, and serum-compatible transfection agent in a viral size. , 2006, Journal of the American Chemical Society.

[16]  R. Straubinger,et al.  Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. , 1993, Cancer research.

[17]  A. Bangham,et al.  NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. , 1964, Journal of molecular biology.

[18]  M. Wenk,et al.  Paclitaxel partitioning into lipid bilayers. , 1996, Journal of pharmaceutical sciences.

[19]  K. Maruyama,et al.  Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). , 1992, Biochimica et biophysica acta.

[20]  A. Chang,et al.  Weekly paclitaxel in advanced non-small cell lung cancer. , 2001, Seminars in oncology.

[21]  Masashi Otsuki,et al.  Incorporation of lipid domains in Cerasome, a morphologically-stable organic-inorganic vesicular nanohybrid , 2006 .